Possibly even more significantly, precise inhibition of PDE4D, whether through genetic approaches or by employing the PDE4D inhibitor Gebr-7b, re-established chemosensitivity in estrogen receptor-positive breast cancer cells that had become resistant to chemotherapy (33). This evidence concerns the gene ESR1 and breast carcinoma.